Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,440.65 15.80 0.10%
S&P 500 1,866.80 4.49 0.24%
NASDAQ 4,107.86 21.63 0.53%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

DATATRAK ONE CLINICAL ERP™ Solution Introduced at DIA



            DATATRAK ONE CLINICAL ERP™ Solution Introduced at DIA

A new, more Intuitive User Interface with Unequalled User-Level
Configurability

PR Newswire

CLEVELAND, June 24, 2013

CLEVELAND, June 24, 2013 /PRNewswire/ -- DATATRAK  International, Inc. (OTCQX:
DTRK), a leader in developing cloud-based, unified eClinical® technologies and
delivering related services for the clinical trials industry, today announced
its next generation clinical trial management enterprise resource planning
(ERP) solution. The DATATRAK ONE CLINICAL ERP™ release streamlines the
clinical trial process through enhancements to DATATRAK's single database
architecture. Data is now informational, actionable and visible for faster,
better decision making.

(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO )

The DATATRAK ONE CLINICAL ERP™ solution is designed with a new, more intuitive
user interface providing improved workflows and mobility. The global,
real-time view of data enables users to proactively identify and address
concerns that result in higher quality and operational efficiencies throughout
the drug development process.

"With the revolutionary DATATRAK ONE CLINICAL ERP™ release, DATATRAK has set
the new standard for eClinical solutions," stated Laurence P. Birch,
DATATRAK's Chairman of the Board and CEO. "Users are now able to configure
their desktop and workflows to reflect their personal preferences as well as
display the data, tasks and reports that are pertinent during each phase of
the study. Essentially, users can continuously customize their views and user
preferences to facilitate the collection, cleaning and submission of clinical
data, thus creating the most advanced user experience in eClinical solutions
today."

In addition to the release of the DATATRAK ONE CLINICAL ERP™ solution,
DATATRAK is demonstrating uPRO, its new patient reported outcomes solution and
uEDC's new Partial Metadata functionality.

The DATATRAK ONE™ suite of products empowers Sponsors and CROs to efficiently
design, deliver and manage clinical trials. The unified, end-to-end clinical
research offering extends the DATATRAK ONE CLINICAL ERP™ system by providing a
comprehensive suite of seven products – all sold standalone or together and
delivered globally in a secure cloud: uCTMS, uDesign, uEDC, uIRT, uPRO,
uSafety and uTrain

Join DATATRAK Thought Leaders:

  o LinkedIn
  o SlideShare
  o The DATATRAK Blog
  o Facebook

Tweet: DATATRAK ONE CLINICAL ERP™ Introduction http://bit.ly/11HHivI 

About DATATRAK
DATATRAK International is a worldwide technology and services company
delivering unified eClinical® solutions and related services for the clinical
trials industry. DATATRAK built its multi-component, comprehensive solution on
a single, unified platform and expanded this concept to include services
delivery via DATATRAK's Clinical and Consulting Services group. The Company
delivers a complete portfolio of software products designed to accelerate the
reporting of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely integrated
technologies. The DATATRAK ONE™ software solution, deployed worldwide through
an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and
device studies in multiple languages throughout the world. DATATRAK has
offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North
Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the
statements made in this release are forward-looking statements. These
forward-looking statements are made based on management's expectations,
assumptions, estimates and current beliefs concerning the operations, future
results and prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are beyond the
control of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking statements. For a
list of certain factors that may cause actual results to differ materially
from those contemplated in these forward looking statements, please see the
Company's report filed with the OTCQX Market on May 15, 2013 announcing its
results for the first quarter of 2013. The Company undertakes no obligation to
update publicly or revise any forward-looking statement whether as a result of
new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Website: http://www.datatrak.net
Contact: Lisa Pahl, Director Marketing, DATATRAK International, Inc.,
+1-979-393-9025
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement